ABSTRACT
Background: Multidisciplinary management of the COVID's patients is essential for their evolution, and the early detection ok AKI is a important role to avoid morbimortality. In March 2020, the pandemic by COVID-19 appeared in Mexico, and it led all the health system to change the intrahospital management. Methods: In a retrospective, observational analysis of all the patients >18 Y that were hospitalized at the Hospital Universitario de Monterrey, in the COVID area, from March to August 2020, we notice how the urinary sedimentation evaluation from the beginning could detect patients who could develop AKI or the need of RRT. All data were analyzed using SPSS statistical software (version 25;IBM Corporation, Armonk, New York). Results: A total of 344 patients hospitalized from March to August 2020. 220 patients with EGO since the beginning (obtained when our nephrology team take place on the presential participation on AEMA) 102 did not have proteinuria, and, on the other hand, the rest (61 or 37%) reported it. 95 patients (41.7%) had hematuria. Hematuria were more likely to be treated with KRT. Patients with hematuria demonstrated an increased tendency to require RRT: 38.2% of patients with hematuria versus 11.6% without hematuria, the greater chance that needs RRT (P<.001). Conclusions: The presence of active sedimentary urinary on COVID patients is frequent. The patients who present the combination of hematuria and proteinuria develop severe AKI (KDIGO 3 without RRT) or the need for RRT. Factors in patients such as to be on their upper edge of 40 years old, the presence of hyperkalemia, metabolic acidosis, also the hematuria and proteinuria, suggest the AKI risk that required RRT.